Jang, E., Lee, Y., Ko, E., Jeong, M., Chang, J., & Lee, H. "Development of lipid nanoparticle formulation for intramuscular administration of mRNA vaccine against respiratory syncytial virus." Journal of Pharmaceutical Investigation (2025): 1-13.   doi: 10.1007/s40005-024-00719-1

Kim, Jooyoung, and Jun Chang. "Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2." Vaccine 42.15 (2024): 3505-3513.  doi: 10.1016/j.vaccine.2024.04.054

Hyun-Jung Kong, Youngwon Choi, Eun-Ah Kim, Jun Chang. “Vaccine strategy that enhances the protective efficacy of systemic immunization by establishing lung-resident memory CD8 T cells against influenza infection. Immune Network 23.4 (2023). doi: 10.4110/in.2023.23.e32 

Chung, Hae-Rynn, Eun-Ah Kim, and Jun Chang. "A “Prime and Deploy” Strategy for Universal Influenza Vaccine Targeting Nucleoprotein Induces Lung-Resident Memory CD8 T cells." Immune Network 21.4 (2021): 28-28. doi: 10.4110/in.2021.21.e28 

Chang, Jun. "MHC multimer: A Molecular Toolbox for Immunologists." Molecules and Cells 44.5 (2021): 328-334. doi.org/10.14348/molcells.2021.0052 

Chang, Jun. "Adenovirus Vectors: Excellent Tools for Vaccine Development." Immune Network 21.1 (2021): 6-6. doi: 10.4110/in.2021.21.e6 

MH Kim, HJ Kim, J Chang (2019) Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East Respiratory Syndrome Coronavirus. PLoS ONE 14(7), e0220196.   DOI: 10.1371/journal.pone.0220196

MH Kim, JO Kang, JY Kim, HE Jung, HK Lee, J Chang (2019) Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus. Antiviral Research 163, 19-28  DOI:10.1016/j.antiviral.2019.01.002

IS Cheon, JY Kim, Y Choi, TJ Braciale, H Youn, MK Song#, J Chang# (2019) Sublingual Immunization With an RSV G Glycoprotein Fragment Primes IL-17-Mediated Immunopathology Upon Respiratory Syncytial Virus Infection. Frontiers in Immunology 10, 567 (#denotes co-corresponding author)   DOI:10.3389/fimmu.2019.00567

Lee, J. Y., & Chang, J. (2017). Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8+ T-cell immunity against respiratory syncytial virus infection. Journal of Microbiology, 55(11), 900-908.  DOI:10.1007/s12275-017-7306-6

Lee, J. Y., & Chang, J. (2017). Universal vaccine against respiratory syncytial virus A and B subtypes. PLoS ONE, 12(4), e0175384.   DOI:10.1371/journal.pone.0175384

Lee, H. J., Lee, J. Y., Park, M. H., Kim, J. Y., & Chang, J. (2017). Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases. PLoS ONE, 12(1), e0169139.   DOI:10.1371/journal.pone.0169139

Kim JY, and Chang J. (2016) In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus. Yonsei Med J. 57(4): 809-16.   DOI:10.3349/ymj.2016.57.4.809

Kang, JO, Lee, JB, and Chang, J. (2016). Cholera Toxin Promotes Th17 Cell Differentiation by Modulating Expression of Polarizing Cytokines and the Antigen-Presenting Potential of Dendritic Cells. PLoS ONE 11(6): e0157015.    DOI:10.1371/journal.pone.0157015

Sim SH, Kim JY, Seong BL, Nguyen HH, and Chang J. (2016) Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice. PLoS ONE 11(3): e0152485   DOI:10.1371/journal.pone.0152485